Citations

Clear

4847 citation(s) found for "Yu, Eric".

Video Tutorial for Indocyanine Green Lymphography in Lymphatic Surgery
Klingelhoefer, Eric , Schiltz, Daniel , Ranieri, Marco, Baringer, Magnus, Heidekrueger, Paul I. , Forte, Antonio J. , Prantl, Lukas , Aung, Thiha , Forte, Antonio Jorge , Brébant, Vanessa

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | January 24, 2020 | Volume: 8 | Issue: 1 | Pages: e2609

10.1097/gox.0000000000002609 | PMID 32095412 Get It

Screening for Primary Aldosteronism: Implications of an Increased Plasma Aldosterone/Renin Ratio
Schwartz, Gary L. , Chapman, Arlene B. , Boerwinkle, Eric , Kisabeth, Robert M, Chapman, Arlene B. , Turner, Stephen T.

Mayo Clinic

Clinical Chemistry | January 23, 2020 | Volume: 48 | Issue: 11 | Pages: 1919-1923

10.1093/clinchem/48.11.1919 Get It

Abstract Background: The value of the ratio of plasma aldosterone concentration (aldosterone) to plasma renin activity (renin) to identify patients at risk for primary aldosteronism is controversial. We determined the sensitivity, specificity, and predictive value of the ratio to identify combinations of renin and aldosterone compatible with primary aldosteronism. Methods: The ratio was calculated in 505 adults with essential hypertension (143 black women, 82 black men, 122 white women, and 158 white men). We used a conventional cutpoint for an increased ratio (i.e., 20 mL/dL · h). The primary combination of renin and aldosterone considered compatible with primary aldosteronism was increased aldosterone for the concomitant renin, defined as aldosterone in the highest quartile predicted by linear regression on renin. Renin was considered low if it was in the lowest quartile of the sample distribution. Results: The sensitivity of the ratio to identify individuals with increased aldosterone for the concomitant renin was 66% (80% in blacks and 56% in whites; P = 0.009), and the specificity of the ratio was 67% (46% in blacks and 84% in whites; P <0.0001). In 36% of instances of an increased ratio, it was a measure of low renin alone without increased aldosterone for renin (32% in blacks and 45% in whites; P = 0.072). The positive predictive value of the ratio to identify individuals with increased aldosterone for the concomitant renin was 34% (49% in whites and 27% in blacks; P <0.002). Conclusion: The aldosterone/renin ratio lacks sensitivity and specificity and has only a modest predictive value for combinations of renin and aldosterone that are compatible with primary aldosteronism.
Serum Neuron-Specific Enolase in Patients with Pituitary Adenoma
Heshmati, Hassan , Foubert, L., Turpin, G, Touitou, Yvan , Foubert, Luc, Young, William F. , Bruckert, Éric

Mayo Clinic

Clinical Chemistry | January 23, 2020 | Volume: 43 | Issue: 3 | Pages: 540-541

10.1093/clinchem/43.3.540 Get It

Sex Differences in Ultrasound-Based Muscle Size and Mechanical Properties of the Cervical-Flexor and -Extensor Muscles
Nagai, Takashi , Schilaty, Nathan D. , Crowley, Eric M., Hewett, Timothy E. , Nagai, Takashi , Schilaty, Nathan D , Krause, David A.

Mayo Clinic

Journal of Athletic Training | January 22, 2020 | Volume: 55 | Issue: 3 | Pages: 282-288

10.4085/1062-6050-482-18 | PMID 31967864 Get It

Context Neck pain (NP), neck injuries, and concussions are more prevalent in female athletes than in their male counterparts. Females exhibit less neck girth, strength, and stiffness against a perturbation. As part of the clinical examination for individuals with NP, ultrasound (US)–based imaging of the cervical muscles has become common. Muscle size or thickness and stiffness can be measured with US-based B-mode and shear-wave elastography (SWE), respectively. Information on reliability, normative values, and sex differences based on US-based muscle size or thickness and stiffness in young and athletic individuals is limited. Objective To evaluate sex differences in US-based muscle size or thickness and biomechanical properties of the cervical-flexor and -extensor muscles. Design Cross-sectional study. Setting Laboratory. Patients or Other Participants A total of 13 women (age = 23.7 ± 1.9 years, height = 167.1 ± 6.1 cm, mass = 63.8 ± 5.6 kg) and 11 men (age = 25.6 ± 4.9 years, height = 178.7 ± 8.3 cm, mass = 78.9 ± 12.0 kg). Main Outcome Measure(s) The same examiner collected all measures, using US B-mode to scan the cross-sectional area and thickness of the longus colli (LC), sternocleidomastoid (SCM), cervical-extensor muscles, and upper trapezius (UT) muscle. The US SWE-mode was used to measure the stiffness of the SCM and UT. Independent t tests or Mann-Whitney U tests were calculated to determine sex differences. The intraclass correlation coefficient (ICC) measured intrarater test-retest reliability. Results Men had thicker SCMs than women (P = .01). No sex differences were present for longus colli cross-sectional area, cervical-extensor muscle thickness, or UT thickness (P > .05). In addition, no sex differences were evident for SCM (P = .302) or UT (P = .703) SWE stiffness. Reliability was good to excellent (ICC = 0.715–0.890) except for SCM SWE stiffness (ICC = 0.554). Conclusions The only sex difference was in SCM thickness. However, smaller SCMs in women did not result in less SCM SWE stiffness. We provided normative values for US-based imaging of the cervical-flexor and -extensor muscles in young and athletic men and women.
Strategies for effective physics plan and chart review in radiation therapy: Report of AAPM Task Group 275
Ford, Eric , Santos, L Fong de los, Greener, Anne, Kim, Grace Gwe‐Ya, Johnson, Jennifer L. , Johnson, Perry , Napolitano, Brian, Parker, S. , Schofield, Deborah , Smith, Koren, Yorke, Ellen , Wells, Michelle, de Los Santos, Luis Fong, Conroy, Leigh , Dong, Lei , Santos, Luis E. Fong de los, Mechalakos, James

Mayo Clinic

Medical Physics | January 22, 2020 | Volume: 47 | Issue: 6 | Pages: No page available

10.1002/mp.14030 | PMID 31967655 Get It

Background While the review of radiotherapy treatment plans and charts by a medical physicist is a key component of safe, high‐quality care, very few specific recommendations currently exist for this task. Aims The goal of TG‐275 is to provide practical, evidence‐based recommendations on physics plan and chart review for radiation therapy. While this report is aimed mainly at medical physicists, others may benefit including dosimetrists, radiation therapists, physicians and other professionals interested in quality management. Methods The scope of the report includes photon/electron external beam radiotherapy (EBRT), proton radiotherapy, as well as high‐dose rate (HDR) brachytherapy for gynecological applications (currently the highest volume brachytherapy service in most practices). The following review time points are considered: initial review prior to treatment, weekly review, and end‐of‐treatment review. The Task Group takes a risk‐informed approach to developing recommendations. A failure mode and effects analysis was performed to determine the highest‐risk aspects of each process. In the case of photon/electron EBRT, a survey of all American Association of Physicists in Medicine (AAPM) members was also conducted to determine current practices. A draft of this report was provided to the full AAPM membership for comment through a 3‐week open‐comment period, and the report was revised in response to these comments. Results The highest‐risk failure modes included 112 failure modes in photon/electron EBRT initial review, 55 in weekly and end‐of‐treatment review, 24 for initial review specific to proton therapy, and 48 in HDR brachytherapy. A 103‐question survey on current practices was released to all AAPM members who self‐reported as working in the radiation oncology field. The response rate was 33%. The survey data and risk data were used to inform recommendations. Discussion Tables of recommended checks are presented and recommendations for best practice are discussed. Suggestions to software vendors are also provided. Conclusions TG‐275 provides specific recommendations for physics plan and chart review which should enhance the safety and quality of care for patients receiving radiation treatments.
Orthobiologics for the Hip Region: A Narrative Review
McInnis, Kelly C. , Chen, Eric T. , Finnoff, Jonathan T. , Roh, Eugene Y. , Stein, Joanne Borg, Finnoff, Jonathan T , Chen, Eric T.

Mayo Clinic

PM&R | January 18, 2020 | Volume: 12 | Issue: 10 | Pages: 1045-1054

10.1002/pmrj.12327 | PMID 31953917 Get It

Management of hip region disorders is challenging. Orthobiologic treatments including platelet rich plasma (PRP), mesenchymal stem cells, and amniotic injectables have gained popularity as promising treatments despite a lack of robust evidence for their effectiveness. We review rationale and current evidence for orthobiologics for three common hip region conditions: hip osteoarthritis, gluteal tendinopathy, and proximal hamstring tendinopathy. Overall, the current state of evidence is extremely limited for orthobiologic treatments and is predominantly relevant to PRP injections. There is currently a lack of data to support the use of mesenchymal stem cells or amniotic injectables in these conditions of the hip.
A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen
Kast, Richard E. , Michael, Alex P. , Sardi, Iacopo , Heiland, Tim, Karpel‐Massler, Georg , Kamar, F. G. , Halatsch, Marc‐Eric , Halatsch, Marc-Eric , Sardi, Iacopo , Burns, Terry C.

Mayo Clinic

Brain Sciences | January 17, 2020 | Volume: 10 | Issue: 1 | Pages: 51

10.3390/brainsci10010051 | PMID 31963414 Get It

Prognosis for diffuse intrinsic pontine glioma (DIPG) and generally for diffuse midline gliomas (DMG) has only marginally improved over the last ~40 years despite dozens of chemotherapy and other therapeutic trials. The prognosis remains invariably fatal. We present here the rationale for a planned study of adding 5-aminolevulinic acid (5-ALA) to the current irradiation of DIPG or DMG: the 5aai regimen. In a series of recent papers, oral 5-ALA was shown to enhance standard therapeutic ionizing irradiation. 5-ALA is currently used in glioblastoma surgery to enable demarcation of overt tumor margins by virtue of selective uptake of 5-ALA by neoplastic cells and selective conversion to protoporphyrin IX (PpIX), which fluoresces after excitation by 410 nm (blue) light. 5-ALA is also useful in treating glioblastomas by virtue of PpIX’s transfer of energy to O2 molecules, producing a singlet oxygen that in turn oxidizes intracellular DNA, lipids, and proteins, resulting in selective malignant cell cytotoxicity. This is called photodynamic treatment (PDT). Shallow penetration of light required for PpIX excitation and resultant energy transfer to O2 and cytotoxicity results in the inaccessibility of central structures like the pons or thalamus to sufficient light. The recent demonstration that keV and MeV photons can also excite PpIX and generate singlet O2 allows for reconsideration of 5-ALA PDT for treating DMG and DIPG. 5-ALA has an eminently benign side effect profile in adults and children. A pilot study in DIPG/DMG of slow uptitration of 5-ALA prior to each standard irradiation session—the 5aai regimen—is warranted.
Protein‐elongating mutations inMYH11are implicated in a dominantly inherited smooth muscle dysmotility syndrome with severe esophageal, gastric, and intestinal disease
Gilbert, Melissa A. , Schultz‐Rogers, Laura , Wilkins, Benjamin J. , Biswas, Sawona , Conlin, Laura K. , Fiorino, Kristin, Dhamija, Radhika , Pack, Michael , Klee, Eric W. , Piccoli, David A., Spinner, Nancy B. , Spinner, Nancy B , Dhamija, Radhika , Rajagopalan, Ramakrishnan , Grochowski, Christopher M.

Mayo Clinic

Human Mutation | January 16, 2020 | Volume: 41 | Issue: 5 | Pages: 973-982

10.1002/humu.23986 | PMID 31944481 Get It